IL-6 Receptor-Alpha Inhibitor Improves Arthritic Kids’ Quality of Life

(MedPage Today) — Children with juvenile idiopathic arthritis (JIA) experienced significant benefits in health-related quality of life when treated with tocilizumab (Actemra), a secondary analysis of clinical trial data found.
Among patients…
Read More

Leave a Reply

%d bloggers like this: